RUNX2 and acute promyelocytic leukemia: MiR-128a, which is upregulated in Acute Myeloid Leukemia (AML), is also a potential regulator of TTP expression, as demonstrated in AML cells (OCI-AML3 and APL/AML cells), where its knockdown strongly triggers TTP expression [207].